Millennium Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,098
| Closed | -$43.9K | – | 4808 |
|
|
2023
Q2 | $43.9K | Sell |
6,098
-4,813
| -44% | -$34.7K | ﹤0.01% | 3980 |
|
|
2023
Q1 | $80K | Buy |
10,911
+3,509
| +47% | +$25.7K | ﹤0.01% | 4115 |
|
|
2022
Q4 | $49K | Sell |
7,402
-1,223
| -14% | -$8.1K | ﹤0.01% | 4453 |
|
|
2022
Q3 | $88K | Sell |
8,625
-4,836
| -36% | -$49.3K | ﹤0.01% | 4729 |
|
|
2022
Q2 | $164K | Buy |
+13,461
| New | +$164K | ﹤0.01% | 4531 |
|
|
2021
Q3 | – | Sell |
-948
| Closed | -$157K | – | 5585 |
|
|
2021
Q2 | $157K | Buy |
+948
| New | +$157K | ﹤0.01% | 4765 |
|